Kyverna CFO granted 325,000 stock options
Kyverna Therapeutics, Inc. reported that Chief Financial Officer Gregory S. Martini received a grant of stock options covering 325,000 shares of common stock.
Rhea-AI Filing Summary
Kyverna Therapeutics, Inc. reported that Chief Financial Officer Gregory S. Martini received a grant of stock options covering 325,000 shares of common stock. The options have an exercise price of $8.54 per share and expire on May 18, 2036. One quarter of the option grant vests on May 18, 2027, with the remaining shares vesting in equal monthly installments over the following three years, contingent on his continuous service. Following this compensation-related award, Martini holds 325,000 derivative securities directly, with no open-market purchases or sales reported in this filing.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 325,000 shares
Grant/Award
1 txn
Insider
Martini Gregory S.
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 325,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 325,000 contracts (Direct)
Footnotes (1)
- F1. 1/4th of the shares subject to the option shall vest on May 18, 2027, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
Key Figures
Options granted: 325,000 options
Exercise price: $8.54 per share
Expiration date: May 18, 2036
+2 more
5 metrics
Options granted
325,000 options
Stock Option (right to buy) grant to CFO on May 18, 2026
Exercise price
$8.54 per share
Exercise price for CFO stock option grant
Expiration date
May 18, 2036
Option term end for CFO grant
Underlying shares
325,000 shares
Common stock underlying the granted options
Post-grant derivative holdings
325,000 options
Total derivative securities held directly after transaction
Key Terms
Stock Option (right to buy), exercise price, expiration date, vesting, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 8.5400"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-05-18T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"1/4th of the shares subject to the option shall vest on May 18, 2027, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What did Kyverna Therapeutics (KYTX) disclose in this Form 4 for its CFO?
Kyverna reported that CFO Gregory S. Martini received a grant of stock options for 325,000 shares of common stock at a $8.54 exercise price as part of his compensation, with future vesting based on continued service.
How many Kyverna (KYTX) stock options were granted to CFO Gregory S. Martini?
Gregory S. Martini was granted options on 325,000 Kyverna common shares. These derivative securities give him the right to buy shares at a fixed $8.54 exercise price if and when the options vest over time.
What is the exercise price and expiration date of the Kyverna (KYTX) CFO’s options?
The stock options granted to Kyverna’s CFO carry an exercise price of $8.54 per share and expire on May 18, 2036. This long-dated term allows potential exercise well into the future if vesting and service conditions are satisfied.
How do the Kyverna (KYTX) CFO’s stock options vest over time?
One quarter of the granted options vest on May 18, 2027. The remaining three quarters vest in equal monthly installments over the next 36 months, conditioned on Gregory S. Martini’s continuous service through each vesting date.
Did the Kyverna (KYTX) Form 4 show any open-market buying or selling by the CFO?
The Form 4 shows only a compensation-related grant of stock options, coded as an acquisition (A), with no open-market purchases or sales. After this award, the CFO directly holds 325,000 derivative securities tied to Kyverna common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
